Arrhythmias & electrophysiology

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: Navigating Heterogeneity in Clinical Evidence: JACC Evidence Review

J Am Coll CardiolPublished JACC Evidence Review

Authors' conclusion

For most anticoagulation-eligible patients, anticoagulation remains the preferred first-line strategy. LAAC is a reasonable option when long-term anticoagulation is unsafe or unsustainable provided that procedural risk, adjunct antithrombotic feasibility, surveillance needs, and competing mortality are carefully considered. RCT evidence in this latter population is limited, and RCTs in other populations have features that limit their support for LAAC as an alternative to anticoagulation. Because LAAC and anticoagulation offer different types of risk, aligning the most applicable evidence with patient values through shared decision-making is central to care.

Study context

Population
Selected patients with atrial fibrillation (AF)
Participants
>7,000 patients
Comparison
Left atrial appendage closure (LAAC) as an alternative to long-term anticoagulation for preventing stroke or systemic embolism
Outcome
Interpretation of the major randomized controlled trials (RCTs) (OPTION, CLOSURE-AF, CHAMPION-AF)

Main finding

As reported in the abstract

  • Trials are not one coherent evidence base; they differ in patient phenotype, comparator, device generation, postprocedure antithrombotic regimen, endpoint construction, and follow-up duration
  • Patient eligibility as well as thromboembolic and bleeding risk varied markedly across trials

Original publication

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: Navigating Heterogeneity in Clinical Evidence: JACC Evidence Review. J Am Coll Cardiol. Published 12 November 2026. doi:10.1016/j.jacc.2026.09.018

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.